Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13882
Country/Region: Kenya
Year: 2014
Main Partner: Children of God Relief Fund
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: USAID
Total Funding: $1,806,681 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

The Children of God Relief Institute (COGRI) runs the Nyumbani orphanage, Lea Toto program in Nairobi and Nyumbani Village in Kitui targeting HIV infected and affected OVC and their families. This activity is designed to implement a health service delivery program that responds to the Results area 3 and 4 as outlined in USAID/Kenya Implementation Framework (2010-2015).Ultimately COGRI will mitigate the impact of HIV/AIDS and decrease the risk of HIV transmission as well as establish a self-sustaining, community based residential village for OVC in Kitui.

COGRI blends economic empowerment and self-sustaining initiatives across the Programs. Caregivers, whose income has improved as a result, are invited to cost share in supporting their children. Effective linkages and referrals to other institution help in meeting a wide range on needs from our beneficiaries. COGRI has numerous innovative projects like use of solar energy, rain water harvest, broad approach to income generation for caregivers, dry land perm-maculture among other. These initiative are gradually being scaled up and ultimately will result to self-sustenance both program and household level. Beneficiaries are eventually transited to services provided by the county governments. Through its international boards, COGRI is also working to increase the donor base.

COGRI has a robust monitoring and evaluation system which track progress made in all activities implemented. Besides gathering data for both internal and external use, the system is designed to monitor services provided to each individual beneficiary in a longitudinal manner. As implementation progresses, COGRI anticipates to increase more on economic empowerment and reduce more on social support.

Mechanism Allocation by Budget Code for Selected Year
Care: Orphans and Vulnerable Children (HKID) $400,000
Care: TB/HIV (HVTB) $150,000
Care: Pediatric Care and Support (PDCS) $250,000
Testing: HIV Testing and Counseling (HVCT) $6,681
Treatment: Pediatric Treatment (PDTX) $1,000,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 2,835
C2.1.D By Age: 15+ 2015 639
C2.1.D By Age/Sex: <15 Female 2015 1,440
C2.1.D By Age/Sex: <15 Male 2015 1,395
C2.1.D By Age/Sex: 15+ Female 2015 363
C2.1.D By Age/Sex: 15+ Male 2015 276
C2.1.D By Sex: Female 2015 1,803
C2.1.D By Sex: Male 2015 1,671
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 3,474
C2.1.D Sum of Age disaggregates 2015 3,474
C2.1.D Sum of Age/Sex disaggregates 2015 3,474
C2.1.D Sum of Sex disaggregates 2015 3,474
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 3,474
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 3,149
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 3,474
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 14
CARE_CURR Age/sex: <1 Female 2015 74
CARE_CURR Age/sex: <1 Male 2015 84
CARE_CURR Age/sex: 1-4 Female 2015 348
CARE_CURR Age/sex: 1-4 Male 2015 324
CARE_CURR Age/sex: 10-14 Female 2015 584
CARE_CURR Age/sex: 10-14 Male 2015 528
CARE_CURR Age/sex: 15-19 Female 2015 300
CARE_CURR Age/sex: 15-19 Male 2015 242
CARE_CURR Age/sex: 20-24 Female 2015 28
CARE_CURR Age/sex: 20-24 Male 2015 25
CARE_CURR Age/sex: 25-49 Female 2015 29
CARE_CURR Age/sex: 25-49 Male 2015 9
CARE_CURR Age/sex: 5-9 Female 2015 437
CARE_CURR Age/sex: 5-9 Male 2015 459
CARE_CURR Age/sex: 50+ Female 2015 3
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,442
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 1,396
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 360
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 276
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 3,474
CARE_CURR Sum of Age/Sex disaggregates 2015 3,474
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 3,474
CARE_NEW Age/sex: <1 Female 2015 44
CARE_NEW Age/sex: <1 Male 2015 45
CARE_NEW Age/sex: 1-4 Female 2015 31
CARE_NEW Age/sex: 1-4 Male 2015 15
CARE_NEW Age/sex: 10-14 Female 2015 10
CARE_NEW Age/sex: 10-14 Male 2015 11
CARE_NEW Age/sex: 15-19 Male 2015 2
CARE_NEW Age/sex: 5-9 Female 2015 21
CARE_NEW Age/sex: 5-9 Male 2015 27
CARE_NEW Aggregated Age/sex: <15 Female 2015 105
CARE_NEW Aggregated Age/sex: <15 Male 2015 97
CARE_NEW Aggregated Age/sex: 15+ Female 2015 2
CARE_NEW Aggregated Age/sex: 15+ Male 2015 2
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 206
CARE_NEW Sum of Age/sex disaggregates 2015 206
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 206
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 9
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 9
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 9
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 9
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 9
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 9
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 9
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 9
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 9
FN_SITE Sum of Numerator Support Type disaggregates 2015 9
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 9
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 9
HTS_TST Age/sex: <1 Female 2015 39
HTS_TST Age/sex: <1 Female 2015 39
HTS_TST Age/sex: <1 Male 2015 44
HTS_TST Age/sex: <1 Male 2015 42
HTS_TST Age/sex: 1-4 Female 2015 83
HTS_TST Age/sex: 1-4 Female 2015 83
HTS_TST Age/sex: 1-4 Male 2015 72
HTS_TST Age/sex: 1-4 Male 2015 72
HTS_TST Age/sex: 10-14 Female 2015 125
HTS_TST Age/sex: 10-14 Female 2015 124
HTS_TST Age/sex: 10-14 Male 2015 154
HTS_TST Age/sex: 10-14 Male 2015 154
HTS_TST Age/sex: 15-19 Female 2015 175
HTS_TST Age/sex: 15-19 Female 2015 175
HTS_TST Age/sex: 15-19 Male 2015 125
HTS_TST Age/sex: 15-19 Male 2015 125
HTS_TST Age/sex: 20-24 Female 2015 289
HTS_TST Age/sex: 20-24 Female 2015 289
HTS_TST Age/sex: 20-24 Male 2015 259
HTS_TST Age/sex: 20-24 Male 2015 259
HTS_TST Age/sex: 25-49 Female 2015 215
HTS_TST Age/sex: 25-49 Female 2015 215
HTS_TST Age/sex: 25-49 Male 2015 248
HTS_TST Age/sex: 25-49 Male 2015 248
HTS_TST Age/sex: 5-9 Female 2015 122
HTS_TST Age/sex: 5-9 Female 2015 122
HTS_TST Age/sex: 5-9 Male 2015 189
HTS_TST Age/sex: 5-9 Male 2015 189
HTS_TST Age/sex: 50+ Female 2015 71
HTS_TST Age/sex: 50+ Female 2015 74
HTS_TST Age/sex: 50+ Male 2015 68
HTS_TST Age/sex: 50+ Male 2015 68
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 369
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 457
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 752
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 700
HTS_TST Aggregated Age/sex: <15 Female 2015 369
HTS_TST Aggregated Age/sex: <15 Male 2015 457
HTS_TST Aggregated Age/sex: 15+ Female 2015 752
HTS_TST Aggregated Age/sex: 15+ Male 2015 700
HTS_TST By Test Result: Negative 2015 2,087
HTS_TST By Test Result: Negative 2015 2,123
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 2,278
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 2,278
HTS_TST Sum of Age/Sex disaggregates 2015 2,278
HTS_TST Sum of Age/Sex disaggregates 2015 2,278
HTS_TST Sum of Aggregated Age/Sex <15 2015 826
HTS_TST Sum of Aggregated Age/Sex <15 2015 826
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 1,452
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 1,452
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 2,278
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 2,278
HTS_TST Sum of Test Result disaggregates 2015 2,278
HTS_TST Sum of Test Result disaggregates 2015 2,278
HTS_TST_POS By Test Result: Positive 2015 191
HTS_TST_POS By Test Result: Positive 2015 155
OVC_ACC Age: <1 2015 158
OVC_ACC Age: 1-4 2015 672
OVC_ACC Age: 10-14 2015 774
OVC_ACC Age: 15-17 2015 880
OVC_ACC Age: 18+ 2015 94
OVC_ACC Age: 5-9 2015 896
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2015 3,474
OVC_ACC Sex: Female 2015 1,803
OVC_ACC Sex: Male 2015 1,671
OVC_ACC Sum of Age disaggregates 2015 3,474
OVC_ACC Sum of Sex disaggregates 2015 3,474
OVC_SERV Age: 1-4 2015 1,302
OVC_SERV Age: 10-14 2015 1,655
OVC_SERV Age: 15-17 2015 2,187
OVC_SERV Age: 18+ 2015 3,089
OVC_SERV Age: 5-9 2015 1,367
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2015 9,600
OVC_SERV Sex: Female 2015 5,571
OVC_SERV Sex: Male 2015 4,029
OVC_SERV Sum of Age disaggregates 2015 9,600
OVC_SERV Sum of Sex disaggregates 2015 9,600
PP_PREV Age/sex: 10-14 Female 2015 652
PP_PREV Age/sex: 10-14 Male 2015 614
PP_PREV Age/sex: 15-19 Female 2015 491
PP_PREV Age/sex: 15-19 Male 2015 435
PP_PREV Age/sex: 20-24 Female 2015 53
PP_PREV Age/sex: 20-24 Male 2015 60
PP_PREV Age/sex: 25-49 Female 2015 1
PP_PREV Age/sex: 25-49 Male 2015 2
PP_PREV Age/sex: 50+ Female 2015 92
PP_PREV Age/sex: 50+ Male 2015 6
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 2,406
PP_PREV Sum of Age/Sex disaggregates 2015 2,406
PP_PREV Total number of people in the target population 2015 2,406
SI_HIS Existence of a national registry of health facilities that is updated annually 2015 1
SI_HIS Full national facility list coordinated with PEPFAR 2015 1
SI_ME Existence of a national HIV/AIDS M&E system based on the UNAIDS 12 components model 2015 1
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: General Population Prevention Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 2
SITE_SUPP By program area/support type: OVC Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 9
SITE_SUPP Number of unique sites supported by PEPFAR 2015 9
TB_ART Age: 0-4 2015 20
TB_ART Age: 15+ 2015 42
TB_ART Age: 5-14 2015 78
TB_ART Aggregated Age: <15 2015 98
TB_ART Aggregated Age: 15+ 2015 42
TB_ART Female 2015 70
TB_ART Known HIV-positive 2015 84
TB_ART Male 2015 70
TB_ART Newly tested 2015 56
TB_ART Sum of Aggregated Age disaggregates 2015 140
TB_ART Sum of Sex disaggregates 2015 140
TB_ART Sum of Test Status disaggregates 2015 140
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 140
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 140
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 9
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 9
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 9
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 9
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 9
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 9
TB_SCREEN Age: <1 2015 158
TB_SCREEN Age: 1-4 2015 671
TB_SCREEN Age: 10-14 2015 1,112
TB_SCREEN Age: 15-19 2015 543
TB_SCREEN Age: 20-24 2015 53
TB_SCREEN Age: 25-49 2015 38
TB_SCREEN Age: 5-9 2015 896
TB_SCREEN Age: 50+ 2015 3
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 2,837
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 637
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 3,474
TB_SCREEN Sex: Female 2015 1,803
TB_SCREEN Sex: Male 2015 1,671
TB_SCREEN Sum of Age disaggregates 2015 3,380
TB_SCREEN Sum of Aggregated Age disaggregates 2015 3,474
TB_SCREEN Sum of Sex disaggregates 2015 3,474
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 3,474
TX_CURR Age/Sex: <1 Female 2015 10
TX_CURR Age/Sex: <1 Male 2015 6
TX_CURR Age/Sex: 1-4 Female 2015 182
TX_CURR Age/Sex: 1-4 Male 2015 165
TX_CURR Age/Sex: 15+ Female 2015 322
TX_CURR Age/Sex: 15+ Male 2015 262
TX_CURR Age/Sex: 5-14 Female 2015 841
TX_CURR Age/Sex: 5-14 Male 2015 838
TX_CURR Aggregated Age/Sex: <1 Female 2015 10
TX_CURR Aggregated Age/Sex: <1 Male 2015 6
TX_CURR Aggregated Age/Sex: <15 Female 2015 1,033
TX_CURR Aggregated Age/Sex: <15 Male 2015 1,009
TX_CURR Aggregated Age/Sex: 15+ Female 2015 322
TX_CURR Aggregated Age/Sex: 15+ Male 2015 262
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 2,626
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 78
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 51
TX_CURR Sum of age/sex disaggregates 2015 2,042
TX_CURR Sum of Aggregated Age/Sex <15 2015 2,042
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 584
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 2,626
TX_CURR_NGI Age/Sex: <1 Female 2015 10
TX_CURR_NGI Age/Sex: <1 Male 2015 6
TX_CURR_NGI Age/Sex: 1-4 Female 2015 182
TX_CURR_NGI Age/Sex: 1-4 Male 2015 165
TX_CURR_NGI Age/Sex: 15+ Female 2015 322
TX_CURR_NGI Age/Sex: 15+ Male 2015 262
TX_CURR_NGI Age/Sex: 5-14 Female 2015 840
TX_CURR_NGI Age/Sex: 5-14 Male 2015 839
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 10
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 6
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 1,033
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 1,009
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 322
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 262
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 2,626
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 2,626
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 2,042
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 584
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 2,626
TX_NEW Aggregated Grouping by Age: <1 Male 2015 23
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 69
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 68
TX_NEW By Age/Sex: <1 Female 2015 9
TX_NEW By Age/Sex: <1 Male 2015 9
TX_NEW By Age/Sex: 1-4 Female 2015 12
TX_NEW By Age/Sex: 1-4 Male 2015 11
TX_NEW By Age/Sex: 10-14 Female 2015 23
TX_NEW By Age/Sex: 10-14 Male 2015 22
TX_NEW By Age/Sex: 15-19 Female 2015 14
TX_NEW By Age/Sex: 15-19 Male 2015 12
TX_NEW By Age/Sex: 5-9 Female 2015 13
TX_NEW By Age/Sex: 5-9 Male 2015 12
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 137
TX_NEW Sum of Age/Sex disaggregates 2015 137
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 137
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 37
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 24
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 64
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 101
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 22
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 123
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 137
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 41
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 26
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 70
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 111
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 26
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 9
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 9
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 9
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 9
TX_SITE Total number of PEPFAR-supported ART sites 2015 9
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 9
Cross Cutting Budget Categories and Known Amounts Total: $350,000
Economic Strengthening $200,000
Education $100,000
Gender: Gender Equality $50,000
Changing harmful gender norms and promoting positive gender norms
Implementation
Increase gender-equitable access to income and productive resources, including education
Capacity building
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Tuberculosis
End-of-Program Evaluation